(NYSE: AVNT) Avient's forecast annual revenue growth rate of 4.16% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.31%.
Avient's revenue in 2026 is $3,331,500,000.On average, 12 Wall Street analysts forecast AVNT's revenue for 2026 to be $319,826,070,850, with the lowest AVNT revenue forecast at $305,059,223,300, and the highest AVNT revenue forecast at $331,474,453,700. On average, 12 Wall Street analysts forecast AVNT's revenue for 2027 to be $330,465,538,650, with the lowest AVNT revenue forecast at $310,195,518,100, and the highest AVNT revenue forecast at $345,415,825,300.
In 2028, AVNT is forecast to generate $344,590,349,350 in revenue, with the lowest revenue forecast at $327,530,513,050 and the highest revenue forecast at $362,659,100,700.